Discussion · House of Representatives
Frank Pallone, Jr. Democrat
“I want the House to pass this bill. It tells the FDA to update its rules so drug makers can use new scientific methods instead of animal testing.”
“Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in support of H.R. 2821, the FDA Modernization Act 3.0, led by Representative Barragan and Representative Carter of Georgia. The FDA Modernization Act 3.0 would require the Food and Drug Administration to update regulations to replace references to animal tests, data, studies, models, and research in specified sections of Title 21 of the Code of Federal Regulations with references to nonclinical tests. This would bring FDA’s regulations in line with a law passed in 2022 that allowed for alternatives to animal testing in drug development, including those that leverage recent scientific advancements, such as computer modeling and cell-based assays. I encourage all my colleagues to vote ``yes’’ on H.R. 2821, and I reserve the balance of my time.”
Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in support of H.R. 2821, the FDA Modernization Act 3.0, led by Representative Barragan and Representative Carter of Georgia. The FDA Modernization Act 3.0 would require the Food and Drug Administration to update regulations to replace references to animal tests, data, studies, models, and research in specified sections of Title 21 of the Code of Federal Regulations with references to nonclinical tests. This would bring FDA’s regulations in line with a law passed in 2022 that allowed for alternatives to animal testing in drug development, including those that leverage recent scientific advancements, such as computer modeling and cell-based assays. I encourage all my colleagues to vote ``yes’’ on H.R. 2821, and I reserve the balance of my time.